Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Neural Regulation01:37

Neural Regulation

42.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.7K
Stages of Sleep01:22

Stages of Sleep

1.1K
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
1.1K
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

715
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
715

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.

Neurology·2026
Same author

HYPNOSA: Study protocol for a prospective observational cohort of patients with obstructive sleep apnea.

Sleep medicine·2026
Same author

Severe OSA May Be Associated With Endothelial Dysfunction in Patients With Nocturnal Hypertension.

Archivos de bronconeumologia·2026
Same author

Phenogroup-based stratification of cardiovascular risk in obstructive sleep apnea.

American journal of preventive cardiology·2026
Same author

Obstructive sleep apnea risk and its association with diabetic foot ulcer in patients with type 2 diabetes.

Frontiers in endocrinology·2026
Same author

Nocturnal Hypoxemia After Acute Coronary Syndrome in OSA: Risk Marker or Adaptive Signal?

Chest·2026

Related Experiment Video

Updated: Dec 12, 2025

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.9K

Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with

Adriano Targa1,2, Faride Dakterzada3, Ivan Benítez1,2

  • 1Translational Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova-Santa Maria, IRBLleida, Lleida, Spain.

Sleep
|August 9, 2020
PubMed
Summary

Sleep disruption in Alzheimer's disease (AD) patients is linked to specific biomarkers. Lack of deep sleep correlates with higher neurofilament light (NF-L), suggesting NF-L may indicate sleep issues in AD.

Keywords:
Alzheimer’s diseaseNF-LYKL-40biomarkerssleep

More Related Videos

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

65.5K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K

Related Experiment Videos

Last Updated: Dec 12, 2025

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.9K
An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

65.5K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K

Area of Science:

  • Neuroscience
  • Sleep Medicine
  • Biomarker Research

Background:

  • Most sleep and Alzheimer's disease (AD) biomarker studies focus on healthy individuals.
  • Understanding sleep's role in AD pathology is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the association between sleep patterns and AD biomarkers in individuals with mild-moderate AD.
  • To explore how distinct sleep stages correlate with markers of amyloid deposition, tau pathology, neuroinflammation, and neurodegeneration.

Main Methods:

  • Polysomnography was used to assess sleep architecture in 104 mild-moderate AD patients.
  • Cerebrospinal fluid was analyzed for biomarkers including NF-L, YKL-40, and oxidative damage markers.
  • Correlations between sleep parameters (e.g., NREM stages, sleep efficiency) and biomarker levels were examined.

Main Results:

  • Neurofilament light (NF-L) showed a positive correlation with light sleep (N1) and a negative correlation with deep sleep (N3).
  • Chitinase-3-like-1 (YKL-40) was negatively correlated with sleep efficiency and deep sleep (N3).
  • Deep sleep was associated with lower NF-L levels, while light sleep was linked to higher NF-L.

Conclusions:

  • Significant correlations exist between sleep parameters and AD biomarkers related to axonal damage and neuroinflammation (NF-L, YKL-40).
  • A lack of deep sleep is associated with elevated NF-L levels in AD patients.
  • NF-L may serve as a biomarker for sleep disruption in mild-moderate AD, complementing its role in predicting neurodegeneration.